CSG Breaks Ground on $632M Iowa Shell Plant as Defense Orders Bolster Long-Term Outlook

Czechoslovak Group's U.S. subsidiary starts building a $632M plant at Iowa Army Ammunition Plant, aiming for 36,000 shells per month by 2029 amid Pentagon push to boost artillery output.

Construction has officially begun on a new artillery shell factory inside the Iowa Army Ammunition Plant, marking the Czechoslovak Group’s most tangible advance yet into the U.S. defense industrial base. The facility, being built by CSG’s American subsidiary MSM North America, will produce up to 36,000 loaded 155-millimeter artillery rounds per month once it reaches full capacity in 2029. The underlying contract with the U.S. Army is valued at as much as $632 million.

The new plant replaces a production line that has been in service for over five decades and is part of a larger Pentagon push to lift domestic artillery output to 100,000 shells monthly. MSM North America is handling design, construction and commissioning, supported by the group’s European munitions teams. The build-out is expected to take roughly 40 months and will create about 70 skilled jobs on site.

CSG’s footprint in North America is also being widened structurally. A newly formed subsidiary, CSG Land Systems North America, has been established with headquarters in Michigan. The entity will consolidate the U.S. activities of Excalibur Army, Tatra Defence and Tatra Trucks, effectively creating a single platform for the group’s land systems business in the region.

The Iowa project is the latest in a string of expansion moves. Earlier this year, CSG transferred proprietary propellant charge technology to Poland’s munitions maker MESKO to help boost that country’s production capacity. The group continues to benefit from robust global demand for ammunition, a trend that was reflected in its first-quarter 2026 trading update. Revenue climbed 13.8% year-on-year to €1,544 million, and management reaffirmed its full-year guidance: sales between €7.4 billion and €7.6 billion, with an operating EBIT margin of roughly 24% to 25%.

On the stock market, CSG’s shares showed signs of life last week, closing at €14.39 on Friday — a gain of 4.44% in a single session and 5.40% over the week. The bounce came as European defense stocks broadly recovered, with Rheinmetall also climbing back above the €1,000 threshold after sliding as low as €900 the prior week. Investors appear to be positioning ahead of the sector’s next round of quarterly reports, and the loss of a multibillion-euro German frigate project by a competitor had lately frayed nerves.

Yet the share price remains deeply depressed relative to its highs. The current level is roughly 60% below the 52-week peak of €36.05, reached on January 26. At the other end, the stock is just under 18% above its 52-week low of €12.20, hit on June 26 — a signal that a floor may have been established. The sharp sell-off earlier this year was largely triggered by a short-seller report in May that questioned the company’s production capacity and disclosure practices. CSG has consistently rejected the allegations, and although several recovery rallies have followed, the stock has never reclaimed its former heights.

Technically, the outlook remains mixed. The shares are trading below both the 50-day moving average of €15.21 and the 100-day average of €19.91, indicating that the longer-term downtrend is still in place. The 14-day relative strength index stands at 50.7, a neutral reading that suggests no overheating or oversold condition. Meanwhile, the annualized 30-day volatility of 52.68% underscores how sharply the stock can swing on sector news or company-specific developments.

All eyes now turn to the half-year results due in August, which will show how CSG’s billions in capital spending on new production capacity are translating into financial performance. The success of the Iowa ramp-up, coupled with a steady stream of orders from the U.S. military, will be critical in determining whether the recovery in the share price can gain lasting traction. For now, the operational story is one of aggressive expansion; the market’s verdict remains unsettled.